Literature DB >> 31767699

Type I interferon signature predicts response to JAK inhibition in haploinsufficiency of A20.

Daniella Muallem Schwartz1, Sarah A Blackstone2, Natalia Sampaio-Moura3, Sofia Rosenzweig3, Aarohan M Burma2, Deborah Stone3, Patrycja Hoffmann3, Anne Jones3, Tina Romeo3, Karyl S Barron2, Meryl A Waldman4, Ivona Aksentijevich3, Daniel L Kastner3, Joshua D Milner2, Amanda K Ombrello3.   

Abstract

Entities:  

Keywords:  DMARDs (synthetic); cytokines; fever syndromes

Mesh：

Substances：

Year:  2019        PMID： 31767699      PMCID： PMC7507120          DOI： 10.1136/annrheumdis-2019-215918

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease.

Authors:  Florence A Aeschlimann; Ezgi D Batu; Scott W Canna; Ellen Go; Ahmet Gül; Patrycja Hoffmann; Helen L Leavis; Seza Ozen; Daniella M Schwartz; Deborah L Stone; Annet van Royen-Kerkof; Daniel L Kastner; Ivona Aksentijevich; Ronald M Laxer
Journal:  Ann Rheum Dis       Date:  2018-01-09       Impact factor: 19.103

2.  Haploinsufficiency of A20 causes autoinflammatory and autoimmune disorders.

Authors:  Tomonori Kadowaki; Hidenori Ohnishi; Norio Kawamoto; Tomohiro Hori; Kenichi Nishimura; Chie Kobayashi; Tomonari Shigemura; Shohei Ogata; Yuzaburo Inoue; Tomoki Kawai; Eitaro Hiejima; Masatoshi Takagi; Kohsuke Imai; Ryuta Nishikomori; Shuichi Ito; Toshio Heike; Osamu Ohara; Tomohiro Morio; Toshiyuki Fukao; Hirokazu Kanegane
Journal:  J Allergy Clin Immunol       Date:  2017-12-11       Impact factor: 10.793

3.  A20 inhibition of STAT1 expression in myeloid cells: a novel endogenous regulatory mechanism preventing development of enthesitis.

Authors:  Katelijne De Wilde; Arne Martens; Stijn Lambrecht; Peggy Jacques; Michael B Drennan; Karlijn Debusschere; Srinath Govindarajan; Julie Coudenys; Eveline Verheugen; Fien Windels; Leen Catrysse; Rik Lories; Dennis McGonagle; Rudi Beyaert; Geert van Loo; Dirk Elewaut
Journal:  Ann Rheum Dis       Date:  2016-08-22       Impact factor: 19.103

Review 4.  A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models.

Authors:  Tridib Das; Zhongli Chen; Rudi W Hendriks; Mirjam Kool
Journal:  Front Immunol       Date:  2018-02-21       Impact factor: 7.561

5.  Janus kinase 1/2 inhibition for the treatment of autoinflammation associated with heterozygous TNFAIP3 mutation.

Authors:  Ciara M Mulhern; Ying Hong; Ebun Omoyinmi; Thomas S Jacques; Felice D'Arco; Cheryl Hemingway; Paul A Brogan; Despina Eleftheriou
Journal:  J Allergy Clin Immunol       Date:  2019-06-05       Impact factor: 10.793

6.  Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease.

Authors:  Qing Zhou; Hongying Wang; Daniella M Schwartz; Monique Stoffels; Yong Hwan Park; Yuan Zhang; Dan Yang; Erkan Demirkaya; Masaki Takeuchi; Wanxia Li Tsai; Jonathan J Lyons; Xiaomin Yu; Claudia Ouyang; Celeste Chen; David T Chin; Kristien Zaal; Settara C Chandrasekharappa; Eric P Hanson; Zhen Yu; James C Mullikin; Sarfaraz A Hasni; Ingrid E Wertz; Amanda K Ombrello; Deborah L Stone; Patrycja Hoffmann; Anne Jones; Beverly K Barham; Helen L Leavis; Annet van Royen-Kerkof; Cailin Sibley; Ezgi D Batu; Ahmet Gül; Richard M Siegel; Manfred Boehm; Joshua D Milner; Seza Ozen; Massimo Gadina; JaeJin Chae; Ronald M Laxer; Daniel L Kastner; Ivona Aksentijevich
Journal:  Nat Genet       Date:  2015-12-07       Impact factor: 38.330

7.  JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies.

Authors:  Gina A Montealegre Sanchez; Adam Reinhardt; Suzanne Ramsey; Helmut Wittkowski; Philip J Hashkes; Yackov Berkun; Susanne Schalm; Sara Murias; Jason A Dare; Diane Brown; Deborah L Stone; Ling Gao; Thomas Klausmeier; Dirk Foell; Adriana A de Jesus; Dawn C Chapelle; Hanna Kim; Samantha Dill; Robert A Colbert; Laura Failla; Bahar Kost; Michelle O'Brien; James C Reynolds; Les R Folio; Katherine R Calvo; Scott M Paul; Nargues Weir; Alessandra Brofferio; Ariane Soldatos; Angelique Biancotto; Edward W Cowen; John J Digiovanna; Massimo Gadina; Andrew J Lipton; Colleen Hadigan; Steven M Holland; Joseph Fontana; Ahmad S Alawad; Rebecca J Brown; Kristina I Rother; Theo Heller; Kristina M Brooks; Parag Kumar; Stephen R Brooks; Meryl Waldman; Harsharan K Singh; Volker Nickeleit; Maria Silk; Apurva Prakash; Jonathan M Janes; Seza Ozen; Paul G Wakim; Paul A Brogan; William L Macias; Raphaela Goldbach-Mansky
Journal:  J Clin Invest       Date:  2018-06-11       Impact factor: 14.808
  7 in total
  13 in total

Review 1.  Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach.

Authors:  Peter A Nigrovic; Pui Y Lee; Hal M Hoffman
Journal:  J Allergy Clin Immunol       Date:  2020-11       Impact factor: 10.793

Review 2.  JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition.

Authors:  Yiming Luo; Madison Alexander; Massimo Gadina; John J O'Shea; Francoise Meylan; Daniella M Schwartz
Journal:  J Allergy Clin Immunol       Date:  2021-10       Impact factor: 14.290

3.  Genetic and immunologic findings in children with recurrent aphthous stomatitis with systemic inflammation.

Authors:  Martina Girardelli; Erica Valencic; Valentina Moressa; Roberta Margagliotta; Alessandra Tesser; Serena Pastore; Ottavia Spadola; Emmanouil Athanasakis; Giovanni Maria Severini; Andrea Taddio; Alberto Tommasini
Journal:  Pediatr Rheumatol Online J       Date:  2021-05-10       Impact factor: 3.054

Review 4.  Spectrum of Neuroradiologic Findings Associated with Monogenic Interferonopathies.

Authors:  P Benjamin; S Sudhakar; F D'Arco; U Löbel; O Carney; C-J Roux; N Boddaert; C Hemingway; D Eleftheriou; K Mankad
Journal:  AJNR Am J Neuroradiol       Date:  2021-12-23       Impact factor: 3.825

Review 5.  Monogenic Autoinflammatory Diseases: State of the Art and Future Perspectives.

Authors:  Giulia Di Donato; Debora Mariarita d'Angelo; Luciana Breda; Francesco Chiarelli
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

Review 6.  A20 Haploinsufficiency in East Asia.

Authors:  Tomonori Kadowaki; Saori Kadowaki; Hidenori Ohnishi
Journal:  Front Immunol       Date:  2021-11-26       Impact factor: 7.561

7.  Deubiquitination of proteasome subunits by OTULIN regulates type I IFN production.

Authors:  Panfeng Tao; Shihao Wang; Seza Ozen; Pui Y Lee; Jiahui Zhang; Jun Wang; Huan Han; Zhaohui Yang; Ran Fang; Wanxia Li Tsai; Huanming Yang; Erdal Sag; Rezan Topaloglu; Ivona Aksentijevich; Xiaomin Yu; Qing Zhou
Journal:  Sci Adv       Date:  2021-11-19       Impact factor: 14.136

Review 8.  New Horizons in the Genetic Etiology of Systemic Lupus Erythematosus and Lupus-Like Disease: Monogenic Lupus and Beyond.

Authors:  Erkan Demirkaya; Sezgin Sahin; Micol Romano; Qing Zhou; Ivona Aksentijevich
Journal:  J Clin Med       Date:  2020-03-05       Impact factor: 4.241

9.  Molecular Footprints of the Immune Assault on Pancreatic Beta Cells in Type 1 Diabetes.

Authors:  Maikel L Colli; Florian Szymczak; Decio L Eizirik
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-15       Impact factor: 5.555

Review 10.  A20: a master regulator of arthritis.

Authors:  Yongyao Wu; Xiaomin He; Ning Huang; Jiayun Yu; Bin Shao
Journal:  Arthritis Res Ther       Date:  2020-09-21       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.